Veradigm Announces Receipt Of Nasdaq Delisting Notice And Intent To Appeal
Portfolio Pulse from Benzinga Newsdesk
Veradigm, a division of Allscripts Healthcare Solutions (MDRX), has received a delisting notice from Nasdaq. The company intends to appeal against this decision.

September 22, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allscripts Healthcare Solutions (MDRX), parent company of Veradigm, has received a delisting notice from Nasdaq. The company plans to appeal this decision.
Receiving a delisting notice is generally seen as a negative event for a company as it can lead to a decrease in investor confidence and potentially a drop in the stock price. However, the company's intent to appeal may mitigate some of this impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100